These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32342327)

  • 1. An APP mutation family exhibiting white matter hyperintensities and cortical calcification in East China.
    Yi Y; Xiaobin Y; Hui C; Yufa Z; Qiaowei Z; Xingyue H; Huaying C
    Neurol Sci; 2020 Oct; 41(10):2921-2928. PubMed ID: 32342327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease.
    Ryan NS; Biessels GJ; Kim L; Nicholas JM; Barber PA; Walsh P; Gami P; Morris HR; Bastos-Leite AJ; Schott JM; Beck J; Mead S; Chavez-Gutierrez L; de Strooper B; Rossor MN; Revesz T; Lashley T; Fox NC
    Neurobiol Aging; 2015 Dec; 36(12):3140-3151. PubMed ID: 26410308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review.
    Sellal F; Wallon D; Martinez-Almoyna L; Marelli C; Dhar A; Oesterlé H; Rovelet-Lecrux A; Rousseau S; Kourkoulis CE; Rosand J; DiPucchio ZY; Frosch M; Gombert C; Audoin B; Miné M; Riant F; Frebourg T; Hannequin D; Campion D; Greenberg SM; Tournier-Lasserve E; Nicolas G
    J Alzheimers Dis; 2017; 56(1):37-46. PubMed ID: 27858710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease.
    Lee S; Zimmerman ME; Narkhede A; Nasrabady SE; Tosto G; Meier IB; Benzinger TLS; Marcus DS; Fagan AM; Fox NC; Cairns NJ; Holtzman DM; Buckles V; Ghetti B; McDade E; Martins RN; Saykin AJ; Masters CL; Ringman JM; Fӧrster S; Schofield PR; Sperling RA; Johnson KA; Chhatwal JP; Salloway S; Correia S; Jack CR; Weiner M; Bateman RJ; Morris JC; Mayeux R; Brickman AM;
    PLoS One; 2018; 13(5):e0195838. PubMed ID: 29742105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter hyperintensities and patterns of atrophy in early onset Alzheimer's disease with causative gene mutations.
    Mao C; Li J; Huang X; Dong L; Liu C; Peng B; Cui L; Gao J
    Clin Neurol Neurosurg; 2021 Apr; 203():106552. PubMed ID: 33601235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occipital Cortical Calcifications in Cerebral Amyloid Angiopathy.
    Rasing I; Voigt S; Koemans EA; van Zwet E; de Kruijff PC; van Harten TW; van Etten ES; van Rooden S; van der Weerd L; van Buchem MA; van Osch MJP; Greenberg SM; van Walderveen MAA; Terwindt GM; Wermer MJH
    Stroke; 2021 May; 52(5):1851-1855. PubMed ID: 33813865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid Precursor Protein Variant, E665D, Associated With Unique Clinical and Biomarker Phenotype.
    Abbatemarco JR; Jones SE; Larvie M; Bekris LM; Khrestian ME; Krishnan K; Leverenz JB
    Am J Alzheimers Dis Other Demen; 2021; 36():1533317520981225. PubMed ID: 33445953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid PET pattern with dementia and amyloid angiopathy in Taiwan familial AD with D678H APP mutation.
    Huang CY; Hsiao IT; Lin KJ; Huang KL; Fung HC; Liu CH; Chang TY; Weng YC; Hsu WC; Yen TC; Huang CC
    J Neurol Sci; 2019 Mar; 398():107-116. PubMed ID: 30703749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene.
    Rossi G; Giaccone G; Maletta R; Morbin M; Capobianco R; Mangieri M; Giovagnoli AR; Bizzi A; Tomaino C; Perri M; Di Natale M; Tagliavini F; Bugiani O; Bruni AC
    Neurology; 2004 Sep; 63(5):910-2. PubMed ID: 15365148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy.
    Grabowski TJ; Cho HS; Vonsattel JP; Rebeck GW; Greenberg SM
    Ann Neurol; 2001 Jun; 49(6):697-705. PubMed ID: 11409420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease families with amyloid precursor protein mutations.
    Rossor MN; Newman S; Frackowiak RS; Lantos P; Kennedy AM
    Ann N Y Acad Sci; 1993 Sep; 695():198-202. PubMed ID: 8239283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.
    Lee S; Viqar F; Zimmerman ME; Narkhede A; Tosto G; Benzinger TL; Marcus DS; Fagan AM; Goate A; Fox NC; Cairns NJ; Holtzman DM; Buckles V; Ghetti B; McDade E; Martins RN; Saykin AJ; Masters CL; Ringman JM; Ryan NS; Förster S; Laske C; Schofield PR; Sperling RA; Salloway S; Correia S; Jack C; Weiner M; Bateman RJ; Morris JC; Mayeux R; Brickman AM;
    Ann Neurol; 2016 Jun; 79(6):929-39. PubMed ID: 27016429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immunotherapy.
    Beckmann N; Gérard C; Abramowski D; Cannet C; Staufenbiel M
    J Neurosci; 2011 Jan; 31(3):1023-31. PubMed ID: 21248127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel amyloid precursor protein mutation, Val669Leu ("Seoul APP"), in a Korean patient with early-onset Alzheimer's disease.
    Bagyinszky E; Kang MJ; Van Giau V; Shim K; Pyun JM; Suh J; An SSA; Kim S
    Neurobiol Aging; 2019 Dec; 84():236.e1-236.e7. PubMed ID: 31623876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral amyloid angiopathy and dementia.
    Tian J; Shi J; Mann DM
    Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.
    Kulic L; McAfoose J; Welt T; Tackenberg C; Späni C; Wirth F; Finder V; Konietzko U; Giese M; Eckert A; Noriaki K; Shimizu T; Murakami K; Irie K; Rasool S; Glabe C; Hock C; Nitsch RM
    Transl Psychiatry; 2012 Nov; 2(11):e183. PubMed ID: 23149447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy.
    Sleegers K; Brouwers N; Gijselinck I; Theuns J; Goossens D; Wauters J; Del-Favero J; Cruts M; van Duijn CM; Van Broeckhoven C
    Brain; 2006 Nov; 129(Pt 11):2977-83. PubMed ID: 16921174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel APP mutation (D678H) in a Taiwanese patient exhibiting dementia and cerebral microvasculopathy.
    Lan MY; Liu JS; Wu YS; Peng CH; Chang YY
    J Clin Neurosci; 2014 Mar; 21(3):513-5. PubMed ID: 23931937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation.
    Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Harada N; Nishida H; Nakajima H; Inuzuka T
    J Neurol; 2017 Feb; 264(2):373-381. PubMed ID: 28000005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy.
    McCreary CR; Beaudin AE; Subotic A; Zwiers AM; Alvarez A; Charlton A; Goodyear BG; Frayne R; Smith EE
    Neuroimage Clin; 2020; 27():102280. PubMed ID: 32521475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.